Aratana Closes $12 Million Series C Financing to Fund Pipeline Expansion
* Reuters is not responsible for the content in this press release.
For best results when printing this announcement, please click on the link below: http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130131:nPnNY51731 KANSAS CITY, Kan. and BOSTON, Jan. 31, 2013 /PRNewswire/ -- Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today announced it has closed on a $12 million Series C financing. Proceeds will fund the continued expansion of Aratana's pipeline of companion animal therapeutic products. Existing Aratana investors, as well as new investors, participated in the over-subscribed financing. "Aratana is on a strong growth trajectory," stated Steven St. Peter, M.D., President and Chief Executive Officer of Aratana Therapeutics. "As we focus on advancing our current development pipeline toward approval and commercialization, we will use funds from this round to add to our portfolio of animal health products, ensuring Aratana's future growth. We thank our investors for their support and enthusiasm and together we look forward to continued successful execution from our expert senior development and commercial team." About Aratana Therapeutics Aratana Therapeutics is a biopharmaceutical company positioned to deliver high quality new medicines that address significant therapeutic needs for cats and dogs (companion animals). Aratana licenses and develops proprietary, patent-protected compounds acquired from human pharmaceutical and biotechnology companies and then develops strategies to maximize the value of the programs for the animal health market. For more information, please visit www.aratanatherapeutics.com. For Investors & Media: Joshua Drumm, Ph.D. / Andrew Mielach Tiberend Strategic Advisors, Inc. (212) 827-0020 email@example.com firstname.lastname@example.org SOURCE Aratana Therapeutics
- Target holiday cyber breach hits 40 million payment cards
- UPDATE 3-Saab wins Brazil jet deal after NSA spying sours Boeing bid
- Home sales tumble, jobless claims at near nine-month high
- Zuckerberg to sell Facebook shares worth about $2.3 billion
- Special Report: Why Ukraine spurned the EU and embraced Russia